In addition, in lung and breast cancers lacking the tumor suppressor RASSF1A, TGF-β signaling is aberrantly activated, promoting the YAP-SMAD interaction and nuclear translocation, which facilitates TGF-β-mediated oncogenic transcription [106]. Here, TGFB1 is linked to breast carcinoma.